Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Early-Stage Parkinson's Disease (PADOVA): Rationale, Design, and Baseline Data

Tania Nikolcheva,Gennaro Pagano,Nathalie Pross,Tanya Simuni,Kenneth Marek,Ronald B. Postuma,Nicola Pavese, Fabrizio Stocchi,Klaus Seppi,Annabelle Monnet, Nima Shariati,Benedicte Ricci,Loes Rutten-Jacobs,Gesine Respondek,Thomas Kustermann,Kirsten I. Taylor,Dylan Trundell,Paulo Fontoura,Rachelle Doody,Hanno Svoboda,Azad Bonni, Prasinezumab Study Grp

PARKINSONISM & RELATED DISORDERS（2025）

Cited 0|Views3
Key words
Alpha-synuclein,Clinical trial,Monoamine oxidase,Levodopa,Monoclonal antibodies,Parkinson's disease
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined